Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:617620.
doi: 10.1155/2015/617620. Epub 2015 Oct 5.

Modulatory Effects of Eschscholzia californica Alkaloids on Recombinant GABAA Receptors

Milan Fedurco  1 , Jana Gregorová  2 , Kristýna Šebrlová  2 , Jana Kantorová  2 , Ondřej Peš  2 , Roland Baur  3 , Erwin Sigel  3 , Eva Táborská  2
Affiliations

Modulatory Effects of Eschscholzia californica Alkaloids on Recombinant GABAA Receptors

Milan Fedurco et al. Biochem Res Int. 2015.

Abstract

The California poppy (Eschscholzia californica Cham.) contains a variety of natural compounds including several alkaloids found exclusively in this plant. Because of the sedative, anxiolytic, and analgesic effects, this herb is currently sold in pharmacies in many countries. However, our understanding of these biological effects at the molecular level is still lacking. Alkaloids detected in E. californica could be hypothesized to act at GABAA receptors, which are widely expressed in the brain mainly at the inhibitory interneurons. Electrophysiological studies on a recombinant α 1 β 2 γ 2 GABAA receptor showed no effect of N-methyllaurotetanine at concentrations lower than 30 μM. However, (S)-reticuline behaved as positive allosteric modulator at the α 3, α 5, and α 6 isoforms of GABAA receptors. The depressant properties of aerial parts of E. californica are assigned to chloride-current modulation by (S)-reticuline at the α 3 β 2 γ 2 and α 5 β 2 γ 2 GABAA receptors. Interestingly, α 1, α 3, and α 5 were not significantly affected by (R)-reticuline, 1,2-tetrahydroreticuline, codeine, and morphine-suspected (S)-reticuline metabolites in the rodent brain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Alkaloids identified in the aerial parts of Eschscholzia californica.
Figure 2
Figure 2
(a) LC UV chromatogram of Eschscholzia californica extract before fractionation. Peak identification: (1) reticuline; (2) caryachine; (3) N-methyllaurotetanine; (4) protopine; (5) californidine; (6) allocryptopine; (7) escholtzine; (8) sanguinarine; and (9) chelerythrine. (b) LC-MS trace of “NMT sample” containing 82% N-methyllaurotetanine, 10% reticuline, and 8% caryachine with traces of other alkaloids.
Figure 3
Figure 3
(a) (A) Electrospray ESI trace and (B) tandem MS/MS fragmentation pattern for selected ion m/z 354 corresponding to alkaloid protopine detected in a pharmacy capsule (300 mg) of E. californica (AMM 57426001) following alkaloid extraction and separation (Method A). (b) Electrospray ESI trace (A) and tandem MS/MS profile (B) for 6S,12S-neocaryachine-7-O-methyl ether N-metho salt detected in the same AMM 57426001 sample. Note that m/z 354 for this pavine alkaloid is practically identical to that of protopine; however, it gives quite different fragmentation pattern.
Figure 4
Figure 4
Modulation of recombinant GABAA receptors of different subunit composition by (S)-reticuline. Receptors were expressed in Xenopus oocytes and concentration dependent modulation was determined using electrophysiological techniques. Each curve is the average of three to four determinations (data points ± standard deviation).
Figure 5
Figure 5
Effect of a benzodiazepine antagonist on the potentiation of α 5 β 2 γ 2 GABAA receptors by (S)-reticuline. Application of 0.5 μM GABA was followed by application of 0.5 μM GABA/10 μM (S)-reticuline and subsequently by 0.5 μM GABA/10 μM (S)-reticuline/1 μM Ro15-1788. Providing (S)-reticuline would act at the benzodiazepine site elicited currents would be expected to go back to the size elicited by GABA alone. Instead, a potentiation was observed. Similar observations were made in two additional experiments.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schafer H. L., Schafer H., Schneider W., Elstner E. F. Sedative action of extract combinations of Eschscholtzia californica and Corydalis cava . Arzneimittel-Forschung. 1995;45(2):124–126. - PubMed
    1. Rolland A., Fleurentin J., Lanhers M.-C., et al. Behavioural effects of the American traditional plant Eschscholzia californica: sedative and anxiolytic properties. Planta Medica. 1991;57(3):212–216. doi: 10.1055/s-2006-960076. - DOI - PubMed
    1. Rolland A., Fleurentin J., Lanhers M. C., Misslin R., Mortier F. Neurophysiological effects of an extract of Eschscholzia californica Cham. (Papaveraceae) Phytotherapy Research. 2001;15(5):377–381. doi: 10.1002/ptr.884. - DOI - PubMed
    1. Hanus M., Lafon J., Mathieu M. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Current Medical Research and Opinion. 2004;20(1):63–71. doi: 10.1185/030079903125002603. - DOI - PubMed
    1. Kardos J., Blaskó G., Simonyi M. Enhancement of gamma-aminobutyric acid receptor binding by protopine-type alkaloids. Arzneimittel-Forschung. 1986;36(6):939–940. - PubMed